Tesamorelin is a stabilized GHRH analog with published pharmacology and controlled-study literature on GH-axis signaling.
Sermorelin is a GHRH 1-29 analog studied as a classic pituitary GH-axis research reference.
Hexarelin is a synthetic GH secretagogue research peptide studied in endocrine and cardiometabolic signaling models.
GHRP-6 is an early growth hormone releasing peptide used as a reference point in GH secretagogue literature.
GHRP-2 is a growth hormone secretagogue research peptide studied around ghrelin-receptor activity and GH-release models.
Ipamorelin is a selective growth hormone secretagogue receptor research peptide used in GH-release and endocrine-signaling comparisons.
CJC-1295 with DAC is a longer-acting GHRH analog studied for extended GH-axis signaling and albumin-binding pharmacology.
CJC-1295 No DAC is a short-acting GHRH analog studied as a pituitary GH-axis signaling reference.
KLOW Blend is a multi-compound research blend organized for comparing ingredient roles, overlap, and format architecture in one listing.
TB-500 is a thymosin beta-4 fragment research peptide connected to actin regulation, cell migration, tissue-stress, and wound-model literature.
BPC-157 is a tissue-signaling research peptide discussed in preclinical tissue-stress, gastrointestinal, tendon, and wound-model literature. Human evidence remains limited.
Mazdutide sits in the GLP-1 / glucagon dual-agonist research lane, where interest centers on incretin signaling, energy expenditure, and metabolic markers.
Tirzepatide is a dual GIP / GLP-1 receptor agonist reference point in metabolic research and comparative incretin pharmacology.
Age check
This catalog is for adults reviewing laboratory research materials. Products are not for human or veterinary use.
Access unavailable. You must be 21 or older to enter this site.
